BioCryst Reports Second Quarter 2026 Financial Results

Go back to BioCryst Reports Second Quarter 2026 Financial Results
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) Delayed: 9.62 +0.24 (2.56%)
Previous Close $9.38    52 Week High $10.98 
Open $9.33    52 Week Low $1.63 
Day High $9.80    P/E N/A 
Day Low $9.28    EPS $-0.68 
Volume 1,227,440